The World Health Organization has recently declared the novel coronavirus (2019-nCoV) a global public health emergency. Huang et al.1 reported acute kidney injury (AKI) in 7% of the 41 patients infected with 2019-nCoV, this value was even higher (up to 31%) among intensive-care patients. Furthermore, Li et al.
A patient’s infectivity is determined by the presence of the virus in different body fluids, secretions, and excreta. The persistence and clearance of viral RNA from different specimens of patients with 2019 novel coronavirus disease (COVID-19) remain unclear.
The ongoing new coronavirus pneumonia (Corona Virus Disease 2019,COVID-19) outbreak is spreading in China, but it has not yet reached its peak. Five million people emigrated from Wuhan before lockdown, potentially representing a source of virus infection. Determining case distribution and its correlation with population emigration from Wuhan in the early stage of the epidemic is of great importance for early warning and for the prevention of future outbreaks.
Since early December 2019, the 2019 novel coronavirus disease (COVID-19) has caused pneumonia epidemic in Wuhan, Hubei province of China. This study aims to investigate the factors affecting the progression of pneumonia in COVID-19 patients. Associated results will be used to evaluate the prognosis and to find the optimal treatment regimens for COVID-19 pneumonia.
自2019年12月以来，在中国武汉出现的病毒性肺炎已经逐渐蔓延至全国，导致这个疫情的病原体已经被证实是一种新型冠状病毒，属于β冠状病毒群，国际病毒分类委员会将新型冠状病毒命名为严重急性呼吸系统综合征冠状病毒2(severe acute respiratory syndrome coronavirus 2，SARS-CoV-2),世界卫生组织(WHO)将新型冠状病毒感染的肺炎命名为Corona Virus Disease 2019(COVID-19)[1,2,3,4]。2020年1月30日， WHO正式宣布本次疫情升级为"国际关注的突发公共卫生事件(Public Health Emergency of International Concern，PHEIC)"。
Coronaviruses have in the past been known to be the etiologic agents of mild upper respiratory infections in humans, similar to the ubiquitous and relatively benign "common cold" -type upper respiratory illnesses induced by the human rhinoviruses in adults and children. Subsequent to the severe acute respiratory syndrome (SARS) outbreak in China 2003, and the Middle East respiratory syndrome (MERS) outbreak in the Middle East in 2012
In December 2019, a cluster of viral pneumonia cases of unknown origin emerged in Wuhan, Hubei Province of China. This emergency has attracted global concern, and the World Health Organization (WHO) declared the outbreak a Public Health Emergency of International Concern (PHEIC).
At the end of 2019, a new coronavirus disease (COVID-19) emerged in Wuhan city, Hubei Province, China, which has quickly spread to the whole of China and more than 20 countries.[1,2,3,4] This disease results from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the family Coronaviridae.
Pneumonia caused by a novel coronavirus known as 2019 novel coronavirus disease (COVID-19) appeared in Wuhan, China in December 2019, and approximately 15–30% of patients developed acute respiratory distress syndrome (ARDS) within a short period of time.[2,3]
Emerging infectious diseases represent a serious threat for human public health worldwide[1,2]. The 2019 novel coronavirus (2019-nCoV) caused a pneumonia outbreak originating in Wuhan, China, which is spreading around the country and has affected 32 provinces and regions of China as of January 27, 2020[3,4]. Countries outside China, including Japan, the United States, Thailand, and South Korea, have also reported cases imported from other countries .
Since the outbreak of the novel coronavirus in Wuhan, China, as obstetricians, we also face great challenges. We need to identify pregnant patients with 2019 coronavirus disease (COVID-19) infection timely, and give them appropriate treatment in order to obtain a good maternal and infant prognosis. Here, we would like to share a case and provide some suggestions on how to screen, diagnose and treat pregnant women with COVID-19 infection during the outbreak.
The epidemiology of novel coronavirus (2019-nCoV) infection in some patients is unclear, and the incubation period of the virus can last for 2 weeks, even longer. During the period of latent infection or the period of incubation following infection, the disease may be infectious. As in cases of influenza, some patients develop only upper respiratory tract infection, whereas others with a severe form of the disease develop pneumonia.
A novel coronavirus (2019-nCoV) causing an outbreak of pneumonia in Wuhan, Hubei province of China was isolated in January 2020. This study aims to investigate its epidemiological history, and analyzed the clinical characteristics, treatment regimens and prognosis of patients infected with 2019-nCoV during this outbreak.
Human infections with zoonotic coronaviruses (CoVs), including severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV, have raised great public health concern globally. Here, we report a novel bat-origin CoV causing severe and fatal pneumonia in humans.
Department of Health Science, Technology and Education, National Health Commission of People's Republic of China. Laboratory Biosafety Guide for the Novel Coronavirus [J] . Biosafety and Health,2020,02(00): E001-E001. DOI: 10.3760/cma.j.issn.2096-6962.2020.0001